Harvard Chan School experts offer comments and context about the coronavirus in a variety of media outlets.
Ronald Panganiban, research scientist in the Department of Environmental Health at Harvard T.H. Chan School of Public Health, discusses a recent paper he co-authored with Quan Lu, Cecil K and Philip Drinker Professor of Environmental Physiology, and other…
Third doses of both the Moderna and Pfizer COVID-19 mRNA vaccines were found to be effective in protecting against SARS-CoV-2 infection and severe COVID-19 outcomes, according to a large study.
Developing life-saving vaccines, directing funding toward pandemic preparedness, building collaborations between public and private entities, and ensuring strict and efficient regulation will all be needed to prepare for future health emergencies, said Harvard Chan School's Kizzmekia Corbett at…
Investing more financial resources to accelerate scientific progress toward an effective tuberculosis vaccine will save lives, fight antimicrobial resistance, advance health equity, improve economic growth, and bring a substantial return on investment, according to a new report.
Researchers have discovered a new form of altered drug susceptibility—dubbed antibiotic resilience—that enables Mycobacterium tuberculosis to survive antibiotic treatment.
Amid surges in respiratory infections across the U.S., and the possibility of an uptick in COVID-19 rates, public health experts are offering advice on how people can make Thanksgiving gatherings as safe as possible.
Cuba’s ability to develop homegrown COVID-19 vaccines and immunize most of its citizens should serve as a model for developing countries around the world dealing with public health emergencies, according to a new report.
Federal regulation of research on dangerous pathogens such as COVID-19 has loopholes and lacks clarity, according to experts.
Harvard Chan School's Dyann Wirth offers some thoughts on a new malaria vaccine and its potential impact.